+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genocea Biosciences - logo

Genocea Biosciences is a biopharmaceutical company that develops novel vaccines and immunotherapies to treat infectious diseases. The company uses its proprietary discovery platform AnTigen Lead Acquisition System to design vaccines and immunotherapies that act through T cell immune responses. Its lead product candidate is GEN-003, a therapeutic vaccine or immunotherapy that is in Phase 2 trial for the treatment of genital herpes infections. Founded in 2006, it is headquartered in Cambridge, Massachusetts.

Neoantigen-Based Personalized Cancer Therapeutic Vaccines - Competitive Landscape and Market Forecast to 2035 - Product Thumbnail Image

Neoantigen-Based Personalized Cancer Therapeutic Vaccines - Competitive Landscape and Market Forecast to 2035

  • Report
  • April 2020
  • 150 Pages
  • Global
From
Melanoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Melanoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 3809 Pages
  • Global
From
Genital Herpes - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Genital Herpes - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • October 2021
  • 119 Pages
  • Global
From
Genocea Biosciences Inc (GNCA:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Genocea Biosciences Inc (GNCA:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • May 2023
  • 85 Pages
From
Comprehensive Report on Genocea Biosciences Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Genocea Biosciences Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Loading Indicator